June 2016 Archives

The markets surged for the third day in a row with the Dow leaping 235 points to close at 17,929 after the Bank of England suggested additional stimulus measures in the wake of the Brexit market collapse. Nasdaq surged 63 points to 4,842. 


On the upside


Stone Energy (NYSE: SGY) terminated an agreement with Ensco and entered an agreement with Williams.

 

Akers Biosciences (Nasdaq: AKER) successfully completed a clinical trial for its rapid test for Chlamydia diagnosis PIFA/Chlamydia Rapid Assay. 


Shares of Anavex Life Sciences (Nasdaq: AVXL) extended its gains.


On the downside


Investors locked in profits on Clovis Oncology (Nasdaq: CLVS).


Retreating crude oil prices weighed down shares of EP Energy (NYSE: EPE).

 

Profit taking sent shares of Himax Technologies (Nasdaq: HIMX) lower.


In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 2 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 leaped 28 points to 2,098. Bitcoin soared $28 to $656.

Merger news lifts markets

|

The markets advanced during the midday on merger news with the Dow soaring 117 points to 17,812. Nasdaq climbs 30 points to 4,809. 


On the upside


The Wall Street Journal reported that Mondelez offered a premium of $107 per shares in cash and stock to acquire Hershey (NYSE: HSY).

 

Higher One Holdings (NYSE: ONE) will be acquired by an affiliate of Blackboard for a premium of approximately $260 million in cash. 


Google Capital will invest $46.35 million in Care.com (NYSE: CRCM).


On the downside


Shares of Costamare (NYSE: CMRE) extended its losses.


AirMedia Group (Nasdaq: AMCN) fell again.

 

Retreating crude oil price weigh down shares of Chesapeake Energy (NYSE: CHK).


In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 gained 12 points to 2,083. Bitcoin climbed $31 to $657.

First time applications for unemployment benefits rose modestly but the markets opened higher with the Dow gaining 41 points to 17,735. Nasdaq added 3 points to 4,783. 


On the upside


Bloomberg reported that Lionsgate (NYSE: LGF) was close to finalizing a deal to acquire Starz (Nasdaq: STRZA).

 

Five Star Quality Care (NYSE: FVE) entered a $112.4 million sale and leaseback transaction with Senior Housing Properties Trust (NYSE: SNH). 


Bloomberg reported that BMW partnered with Intel (Nasdaq: INTC) and Mobileye (NYSE: MBLY) to develop self driving cars.


On the downside


Pier 1 Imports (NYSE: PIR) fell to a greater than expected loss for the first quarter on lower revenue and cut its full year revenue forecast.


Retreating crude oil prices weighed down shares of Whiting Petroleum (NYSE: WLL).

 

Ensco (NYSE: ESV) reached an agreement to settle the remaining obligations of a customer's drilling services contract.


In the broad market, declining issues outpaced advancers by a margin of 10 to 9 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The broader S&P 500 added 2 points to 2,073. Bitcoin climbed $35 to $663.

Crude oil rises, markets soar

|

Rising crude oil prices lifted the markets to a higher close with the Dow rocketing 284 points to 17,694. Nasdaq jumped 87 points to 4,779. 


On the upside


Brookfield Asset Management acquired a 12.13% stake in TerraForm Power (Nasdaq: TERP).

 

ChromaDex (Nasdaq: CDXC) was added to the Russell 2000, Russell 3000, Russell Microcap Index and Russell Global Index. 


Bargain hunters lifted shares of Regulus (Nasdaq: VNR).


On the downside


Southwestern Energy (NYSE: SWN) increased its public offering from 75 million shares to 86 million shares.


Alcoa (NYSE: AA) will split into two companies.

 

Shares of Hutchinson Technology (Nasdaq: HTCH) slipped.


In the broad market, advancing issues outpaced decliners by a margin of 6 to 1 on the NYSE and by 7 to 2 on Nasdaq. The broader S&P 500 surged 34 points to 2,070. Bitcoin fell $5 to $633.

Market extends recovery

|

The market recovery continued with the Dow leaping 262 points to 17,672. Nasdaq jumped 89 points to 4,781. 


On the upside


Shares of Twilio (NYSE: TWLO) surged again.

 

Upbeat clinical trial results from Tesaro (Nasdaq: TSRO) lifted shares of Clovis Oncology (Nasdaq: CLVS) which is developing a similar product. 


Rising crude oil prices lifted shares of Vanguard Natural Resources (Nasdaq: VNR).


On the downside


RBC Capital Markets downgraded Esperion Therapeutics (Nasdaq: ESPR) from an Outperform rating to a Sector Perform rating.


Profit taking weighed down shares of 21Vianet Group (Nasdaq: VNET).

 

Kitov Pharmaceuticals (Nasdaq: KTOV) priced its offering of nearly 2.38 million units.


In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 1 on the NYSE and by more than 7 to 2 on Nasdaq. The broader S&P 500 surged 33 points to 2,069. Bitcoin lost $9 to $630.

The markets opened sharply higher for the second day in a row with the Dow soaring 157 points to 17,567 as consumer spending rose 0.4% in May. Nasdaq surged 59 points to 4,750. 


On the upside


Apollo Global Management will pay a premium of approximately $2.2 billion in cash to acquire Diamond Resorts International (NYSE: DRII).

 

Tesaro (Nasdaq: TSRO) reported positive results from a Phase 3 NOVA trial of niraparib to treat ovarian cancer. 


PrivateBancorp (Nasdaq: PVTB) will be acquired by Canadian Imperial Bank of Commerce (NYSE: CM) in a cash and stock deal valued at approximately $3.8 billion.


On the downside


Galena Biopharma (Nasdaq: GALE) will discontinue its Phase 3 PRESENT clinical trial due to futility.


Eclipse Resources (NYSE: ECR) priced its public offering of 37.5 million common shares at the discounted price of $3.50 per share.

 

The Food and Drug Administration issued a Complete Response Letter to Lipocine (Nasdaq: LPCN) for LPCN 1021.


In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 1 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 soared 21 points to 2,057. Bitcoin tumbled $14 to $625.

Market free fall ends

|

The market free fall ended after two days of colossal losses with the Dow leaping 269 points to 17,409. Nasdaq jumped 97 points to 4,691. 


On the upside


U.K. banking stocks Barclays (NYSE: BCS), Lloyds Banking Group (NYSE: LYG) and Royal Bank of Scotland (NYSE: RBS) all rebounded after the Brexit crash.

 

Bank of America (NYSE: BAC), Citigroup (NYSE: C) and JP Morgan (NYSE: JPM) recovered as well. 


Advaxis (Nasdaq: ADXS) webcast their annual Investor & Analyst Day event today.


On the downside


Investors locked in profits on Lipocine (Nasdaq: LPCN).


Profit taking continued to weigh down shares of Tersaro (Nasdaq: TSRO).

 

Shares of Natera (Nasdaq: NTRA) extended its losses.


In the broad market, advancing issues outpaced decliners by a margin of nearly 6 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The broader S&P 500 leaped 35 points to 2,036. Bitcoin held steady at $636.

Bargain hunters lift markets

|

Bargain hunters lifted the markets higher during the midday with the Dow surging 138 points to 17,279. Nasdaq soared 65 points to 4,660. 


On the upside


Xencor (Nasdaq: XNCR) entered a collaboration and license agreement with Novartis to develop and commercialize XmAb 14045 and XmAb 13676.

 

Zacks Equity Research wrote that Rocket Fuel (Nasdaq: FUEL) was one of seven Internet stocks with great charts. 


Endo International (Nasdaq: ENDP) received a patent for Vasostrict.


On the downside


Babcock & Wilcox Enterprises (NYSE: BW) slashed its 2016 profit forecast and announced plans to eliminate 200 jobs.


Piper Jaffray downgraded Meritor (NYSE: MTOR) from a Neutral rating to an Underweight rating.

 

Zacks added Fibrocell Science (Nasdaq: FCSC) to its Zacks Rank #1 List but the stock price fell.


In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The broader S&P 500 climbed 20 points to 2,020. Bitcoin rose $4 to $639.

The markets opened sharply higher after two days of Brexit induced turmoil with the Dow soaring 191 points to 17,332. Nasdaq surged 73 points to 4,667. 


On the upside


Gannett (NYSE: GCI) will pay a premium of approximately $156 million to acquire ReachLocal (Nasdaq: RLOC).

 

Ocean Power Technologies (Nasdaq: OPTT) redeployed the PB3-A1 PowerBuoy off the coast of New Jersey. 


Shares of Twilio (NYSE: TWLO) climbed after making its market debut on Thursday before the Brexit induced market collapse.


On the downside


The Food and Drug Administration placed a clinical hold on Regulus Therapeutics' (Nasdaq: RGLS) Investigational New Drug application for the chronic hepatitis C treatment RG-101.


Telsey Advisory Group downgraded comScore (Nasdaq: SCOR) from an Outperform rating to a Market Perform rating.

 

Profit taking weighed down shares of Barrick Gold (NYSE: ABX) and Kinross Gold (NYSE: KGC).


In the broad market, advancing issues outpaced decliners by a margin of 8 to 1 on the NYSE and by more than 7 to 1 on Nasdaq. The broader S&P 500 soared 23 points to 2,024. Bitcoin rose $4 to $639.

2nd day of financial turmoil

|

A second day of global financial market turmoil sent domestic markets tumbling to close sharply lower with the Dow slumping 260 points to 17,140. Nasdaq crashed 113 points to 4,594. 


On the upside


Shares of Nymox Pharmaceutical (Nasdaq: NYMX) climbed for the second day.

 

TheStreet listed Amedica (Nasdaq: AMDA) as one of five under $10 stocks poised to soar. 


Analysts upgraded Barrick Gold (NYSE: ABX), Coeur Mining (NYSE: CDE) and Eldorado Gold (NYSE: EGO).


On the downside


SS&C Technologies Holdings (Nasdaq: SSNC) completed its 2-for-1 stock split.


Global recession concerns sank shares of Whiting Petroleum (NYSE: WLL).

 

JP Morgan downgraded Deutsche Bank (NYSE: DB) from an Overweight rating to an Underweight rating.


In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by 6 to 1 on Nasdaq. The broader S&P 500 plunged 36 points to 2,000. Bitcoin climbed $17 to $634.

Brexit induced crash continues

|

The Brexit induced financial market crash continued with the Dow plunging 237 points to 17,162. Nasdaq collapsed 97 points to 4,610. 


On the upside


Akers Biosciences (Nasdaq: AKER) signed its first distribution agreement for BreathScan OxiCheck.

 

TheStreet wrote that Fibrocell Science (Nasdaq: FCSC) was one of five under $10 stocks that was poised to climb. 


People's United Financial (Nasdaq: PBCT) will acquire Suffolk Bancorp (NYSE: SCNB) in a deal valued at approximately $402 million.


On the downside


Concerns that the Brexit will trigger a global recession sent shares of Cobalt International Energy (NYSE: CIE) plummeting.


Shares of Charles Schwab (NYSE: SCHW) fell again as investors consider the long term consequences of Brexit.

 

Bank of America (NYSE: BAC), Citigroup (NYSE: C) and Wells Fargo (NYSE: WFC) all fell again as fallout from Brexit continued.


In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 1 on the NYSE and by nearly 6 to 1 on Nasdaq. The broader S&P 500 plunged 34 points to 2,002. Bitcoin gained $11 to $628.

The financial bloodbath continued in the aftermath of the Brexit with the Dow plummeting 264 points to 17,136. Nasdaq plunged 86 points to 4,621. 


On the upside


Medtronic will pay a premium of approximately $1.1 billion in cash to acquire Heartware International (Nasdaq: HTWR).

 

GW Pharmaceuticals (Nasdaq: GWPH) reported positive Phase 3 results for Epidiolex to treat Lennox-Gastaut syndrome. 


Skullcandy (Nasdaq: SKUL) received an unsolicited acquisition offer from Mill Road Capital that topped the $177 million bid from Incipio.


On the downside


Analysts downgraded Barclays (NYSE: BCS), Lloyds Banking (NYSE: LYG) and Royal Bank of Scotland (NYSE: RBS).


Ford (NYSE: F) dealers in Indonesia demanded $75 million in compensation after the automaker suddenly announced in January that all operations would close in that country.

 

Concerns that the Brexit will increase costs for U.K. airlines weighed down shares of Ryanair (Nasdaq: RYAAY).


In the broad market, declining issues outpaced advancers by a margin of more than 5 to 1 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 tumbled 34 points to 2,002. Bitcoin rose $5 to $622.

The surprising decision by British voters to leave the European Union sent global markets into a free fall with the Dow crashing 610 points to 17,400. Nasdaq collapsed 202 points to 4,707. 


On the upside


Investors seeking safe haven assets lifted shares of gold miner Sibanye Gold (NYSE: SBGL).

 

Rising interest in gold investments lifted shares of gold jewelry maker Kingold Jewelry (Nasdaq: KGJI). 


Platinum Equity increased its acquisition offer for Electro Rent (Nasdaq: ELRC) from $13.12 per share to $15.50 per share.


On the downside


Shares of Banco Santander (NYSE: SAN) and Banco Bilbao Vizcaya Argentaria (NYSE: BBVA) plunged in reaction to the Brexit vote.


Bank of America (NYSE: BAC), Citigroup (NYSE: C), Morgan Stanley (NYSE: MS) and Wells Fargo (NYSE: WFC) tumbled along with European banking stocks.

 

Avon (NYSE: AVP) will proceed with plans to relocate its headquarters to the UK despite the Brexit vote.


In the broad market, declining issues outpaced advancers by a margin of more than 5 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 collapsed 75 points to 2,037. Bitcoin soared $36 to $641.

British voters' decision to leave the European Union sparked turmoil in global markets. The Dow extended its losses by diving 514 points to 17,496. Nasdaq collapsed 180 points to 4,729. 


On the upside


Bargain hunters lifted shares of Biostar Pharmaceuticals (Nasdaq: BSPM). 


Seaport Global Securities upgraded Emerge Energy Services (NYSE: EMES) from a Neutral rating to a Buy rating.

 

Rising gold prices lifted shares of Harmony Gold (NYSE: HMY) and Gold Fields (NYSE: GFI).


On the downside


Aviva (NYSE: AV) reassured investors that the Brexit decision would not have a significant impact on its business but the stock price plummeted.


Concerns that the Brexit will have a negative impact on the technology and telecommunications industries sent shares of BT Group (NYSE: BT) plunging.


European banks Credit Suisse (NYSE: CS) and Deutsche Bank (NYSE: DB) plummeted in reaction to the Brexit vote.

 

In the broad market, declining issues outpaced advancers by a margin of nearly 6 to 1 on the NYSE and by nearly 7 to 1 on Nasdaq. The broader S&P 500 plummeted 64points to 2,049. Bitcoin soared $30 to $635.

Brexit wins, markets collapse

|

The United Kingdom's vote to leave the European Union roiled global markets sending the Dow briefly down more than 500 points at the open. The markets pared its losses with the Dow collapsing 402 points to 17,609. Nasdaq plummeted 136 points to 4,773. 


On the upside


Staffing 360 Solutions (Nasdaq: STAF) reported higher preliminary fourth quarter and full year 2016 results. 


Finish Line (Nasdaq: FINL) reported better than expected first quarter earnings and revenue.

 

Skullcandy (Nasdaq: SKUL) will be acquired by Incipio in an all cash deal valued at approximately $177 million.


On the downside


Shares of Lloyds Banking (NYSE: LYG),  Barclays (NYSE: BCS) and The Royal Bank of Scotland (NYSE: RBS) plummeted after Britons voted to leave the European Union.


Telefonica (NYSE: TEF) cited global market turmoil caused by the Brexit for exploring a possible delay to the initial public offering of its Telxius infrastructure unit.


Concerns about a global recession weighed down shares of ArcelorMittal (NYSE: MT).

 

In the broad market, declining issues outpaced advancers by a margin of more than 6 to 1 on the NYSE and by more than 7 to 1 on Nasdaq. The broader S&P 500 plunged 48 points to 2,065. Bitcoin leaped $51 to $656.

Markets surge on Brexit vote

|

The markets closed sharply higher with the Dow rocketing 230 points to 18,011 as investors await Brexit results. Nasdaq leaped 76 points to 4,910. 


On the upside


Shares of Intrepid Potash (NYSE: IPI) climbed on news that India moved closer to signing a potash agreement with Belarus. 


Bloomberg reported that Twitter (NYSE: TWTR) would soon announce deals to stream live events.

 

Rising crude oil prices lifted shares of Clayton Williams Energy (NYSE: CWEI).


On the downside


Khang & Khang filed a class action lawsuit against Tangoe (Nasdaq: TNGO).


CACI International (NYSE: CACI) forecast 2017 results that missed analyst expectations prompting a downgrade.


Iao Kun Group (Nasdaq: IKGH) will acquire Jeju Sun Hotel & Casino.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 1 on the NYSE and by 7 to 2 on Nasdaq. The broader S&P 500 leaped 27 points to 2,113. Bitcoin fell $9 to $597.

Optimism that British voters would chose to remain in the European Union boosted the markets during the midday with the Dow surging 154 points to 17,934. Nasdaq soared 55 points to 4,888. 


On the upside


A surge in Chinese iron ore futures lifted shares of ArcelorMittal (NYSE: MT). 


Ocwen Financial (NYSE: OCN) will settle two lawsuits.

 

A Reuters report that Belarus may cooperate with Russian potash producers lifted shares of Potash Corp. of Saskatchewan (NYSE: POT).


On the downside


Zacks Equity Research wrote that Galena Biopharma (Nasdaq: GALE) was overbought.


Shares of xG Technology (Nasdaq: XGTI) fell for the third day in a row after completing a 1-for-12 reverse stock split.


Investors locked in profits on First Data (NYSE: FDC).

 

In the broad market, advancing issues outpaced decliners by a margin of 6 to 1 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 soared 19 points to 2,104. Bitcoin tumbled $33 to $573.

First time applications for unemployment benefits fell more than expected last week to send the markets soaring to a sharply higher open with the Dow surging 132 points to 17,913. Nasdaq climbed 37 points to 4,870. 


On the upside


Cellectar Biosciences (Nasdaq: CLRB) reported promising results from the first phase of a Phase 1 study of CLR 125 to treat triple negative breast cancer. 


Nomura upgraded Micron Technology (Nasdaq: MU) from a Reduce rating to a Buy rating and lifted price target from $8 to $18.

 

Planet Fitness (NYSE: PLNT) priced its secondary offering of 10 million common shares at $16.50 per share.


On the downside


Whiting Petroleum (NYSE: WLL) entered an exchange agreement of $1.06 billion of notes.


Steelcase (NYSE: SCS) forecast current quarter earnings below expectations.


Red Hat (NYSE: RHT) reported higher first quarter earnings and revenue but the stock price fell after announcing plans to buy 3scale.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 6 to 1 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 climbed 15 points to 2,100. Bitcoin plunged $42 to $564.

The markets closed lower with the Dow falling 48 points to 17,780 on the eve of the Brexit vote. Nasdaq lost 10 points to 4,833. 


On the upside


SunTrust initiated coverage of Unisys (NYSE: UIS) with a Buy rating. 


Pluristem Therapeutics (Nasdaq: PSTI) reported positive results from preclinical studies of PLX-PAD cells to treat Duchenne muscular dystrophy.

 

Sunworks (Nasdaq: SUNW) received $24 million in new commercial orders.


On the downside


QEP Resources (NYSE: QEP) will fund its $600 million purchase of 9,400 acres in the Permian Basin by selling 20 million shares of common stock.


HP (NYSE: HPQ) warned that a change in its printing strategy will lower its free cash flow.


Actuant (NYSE: ATU) reported lower third quarter earnings and revenue and forecast current quarter results below expectations.

 

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on both the NYSE and on Nasdaq. The broader S&P 500 slipped 3 points to 2,085. Bitcoin lost $4 to $603.

Markets fall ahead of Brexit vote

|

The markets turned negative during the midday with the Dow falling 46 points to 17,783 as British voters prepared to vote in tomorrow's Brexit referendum. Nasdaq lost 8 points to 4,835. 


On the upside


Cemtrex (Nasdaq: CETX) will repurchase up to 1 million shares of company stock. 


Aspen Aerogels (NYSE: ASPN) expanded its strategic partnership with BASF.

 

Shares of Stone Energy (NYSE: SGY) climbed for the fourth day.


On the downside


Profit taking weighed down shares of Rosetta Genomics (Nasdaq: ROSG).


BB&T Capital Markets downgraded Covenant Transportation Group (Nasdaq: CVTI) from a Buy rating to a Hold rating.


The Motley Fool said that Advanced Micro Devices (Nasdaq: AMD) could drop.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 slipped 2 points to 2,086. Bitcoin dropped $16 to $629.

The markets opened higher with the Dow climbing 74 points to 17,904 as crude oil prices rebounded. Nasdaq rose 13 points to 4,857. 


On the upside


SkyPeople Fruit Juice (Nasdaq: SPU) subsidiary Hedetang Holdings entered a Share Transfer Agreement with Shaanxi New Silk Road Kiwifruit Group. 


Inventergy Global (Nasdaq: INVT) received patent grants and notices of allowance for 23 patents in telecommunications and mobile broadband.

 

Nymox (Nasdaq: NYMX) reported positive results from a 7 year prospective placebo controlled double blind study of fexapotide to prevent prostate cancer.


On the downside


Tesla (Nasdaq: TSLA) offered a premium of approximately $2.8 billion to acquire SolarCity (Nasdaq: SCTY).


Emergent BioSolutions (NYSE: EBS) will respond to two solicitations issued by the Department of Health and Human Services to develop anthrax vaccines for the Strategic National Stockpile.


Inovio Pharmaceuticals (Nasdaq: INO) chief executive Joseph Kim said that it would take several years before a Zika vaccine would be available.

 

In the broad market, advancing issues outpaced decliners by a margin of 7 to 5 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 gained 7 points to 2,096. Bitcoin climbed $11 to $657.

The markets closed higher with the Dow gaining 24 points to 17,829 after Federal Reserve chair Janet Yellen testified before Congress. Nasdaq rose 6 points to 4,843. 


On the upside


OSI Systems (Nasdaq: OSIS) will pay a premium of approximately $269 million in cash to acquire American Science & Engineering (Nasdaq: ASEI). 


Advanced Micro Devices (Nasdaq: AMD) received the Environmental Leader "Project of the Year" award for its AMD 25x20 Initiative for energy efficiency.

 

Immersion (Nasdaq: IMMR) introduced its TouchSense Design Cloud design toolkit.


On the downside


Shares of U.S. Steel (NYSE: X) and ArcelorMittal (NYSE: MT) fell after ActiveWallSt.com wrote that demand for steel and iron would remain weak until mid-August.


Nikesh Arora, the president and designated successor to chief executive Masayoshi Son of Sprint (NYSE: S) parent company SoftBank, will leave the company.


Shares of Swift Transportation (NYSE: SWFT) fell after rival Werner (Nasdaq: WERN) forecast disappointing earnings.

 

In the broad market, advancing issues outpaced decliners by a margin of 9 to 7 on the NYSE while decliners edged out advancers by more than 7 to 5 on Nasdaq. The broader S&P 500 rose 5 points to 2,088. Bitcoin gained $2 to $648.

Mixed markets as oil retreats

|

The markets traded mixed during the midday with the Dow gaining 22 points to 17,827 as crude oil prices retreated. Nasdaq slipped 2 points to 4,835. 


On the upside


The second day of Williams Cos.' (NYSE: WMB) lawsuit against Energy Transfer Equity (NYSE: ETE) began. 


Shares of Stone Energy (NYSE: SGY) climbed for the third day.

 

WP Glimcher (NYSE: WPG) chief executive Michael Glimcher resigned.


On the downside


xG Technology (Nasdaq: XGTI) completed its 1-for-12 reverse stock split.


Liberty Global (Nasdaq: LBTYK) (Nasdaq: LBTYA) determined the final per share ratio distribution of Liberty Global Latin America and Caribbean ordinary shares to Liberty Global Group shareholders.


Paratek Pharmaceuticals (Nasdaq: PRTK) will offer 3.75 million common shares.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE while decliners edged out advancers by nearly 2 to 1 on Nasdaq. The broader S&P 500 added 4 points to 2,087. Bitcoin tumbled $50 to $672.

The markets opened flat with the Dow rising 19 points to 17,824 as Federal Reserve chair Janet Yellen testified on monetary policy before the Senate Banking Committee. Nasdaq added 4 points to 4,842. 


On the upside


The New York Department of Health granted conditional approval to Rosetta Genomics' (Nasdaq: ROSG) multiple fluorescence in situ hybridization tests for detection of amplifications or rearrangements of DNA in hematologic cancers. 


ChromoDex (Nasdaq: CDXC) said that an anonymous report issued by a short seller yesterday was laden with misinformation and innuendo.

 

Activist investor Paul Singer's Elliott Associates purchased 2.20 million shares of Imperva (NYSE: IMPV).


On the downside


Werner Enterprises (Nasdaq: WERN) warned of lower second quarter earnings prompting a downgrade.


Immunomedics (Nasdaq: IMMU) named Michael R. Garone to replace Peter P. Pfreundschuh as chief financial officer.


Impax Laboratories (Nasdaq: IPXL) will pay approximately $586 million to acquire a portfolio of generic drugs from Teva Pharmaceuticals (NYSE: TEVA) and affiliates of Allergan (NYSE: AGN).

 

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 added 2 points to 2,086. Bitcoin plunged $75 to $646.

Brexit fears ebbed to boost the markets to a sharply higher close with the Dow surging 129 points to 17,804. Nasdaq climbed 36 points to 4,837. 


On the upside


Freeport-McMoRan (NYSE: FCX) will eliminate another 16 jobs in Houston. 


Bargain hunters lifted shares of Genesis Healthcare (NYSE: GEN).

 

Walmart (NYSE: WMT) will sell its Yihaodian Chinese e-commerce business to JD.com (Nasdaq: JD) for a 5% equity stake in JD.com.


On the downside


Investors locked in profits on Biostar Pharmaceuticals (Nasdaq: BSPM).


Shares of Sophiris Bio (Nasdaq: SPHS) dropped for the fourth day.


Energy Transfer Equity (NYSE: ETE) former chief financial officer testified that chief executive officer Kelcy Warren was concerned that a merger with Williams Cos. would prompt downgrades and a plunge in the stock price.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 climbed 12 points to 2,083. Bitcoin fell $8 to $713.

The markets traded higher during the midday with the Dow soaring 182 points to 17,857 as crude oil prices continued to rise. Nasdaq leaped 65 points to 4,865. 


On the upside


Bridgeline Digital's (Nasdaq: BLIN) iAPPS Digital Engagement Platform was selected to power the law and business education system of a global software and services firm. 


The Food and Drug Administration granted Fast Track designation to Fate Therapeutics (Nasdaq: FATE) for its ProTmune to reduce the incidence and severity of acute graft-versus-host disease.

 

Rising crude oil prices lifted shares of Stone Energy (NYSE: SGY).


On the downside


Mizuho downgraded Eagle Pharmaceuticals (Nasdaq: EGRX) from a Buy rating to a Neutral rating.


Cypress Semiconductor (Nasdaq: CY) announced plans to offer $250 million in convertible senior notes.


Morgan Stanley downgraded CVS (NYSE: CVS) from an Overweight rating to an Equal Weight rating.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 1 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 soared 20 points to 2,091. Bitcoin tumbled $16 to $729.

Polls indicating that British voters favor staying in the European Union boosted the markets to a sharply higher open with the Dow leaping 247 points to 17,922. Nasdaq jumped 76 points to 4,877. 


On the upside


Lpath (Nasdaq: LPTN) received a $1.45 million two-year grant from the Defense Medical Research and Development Program to study Lpathomab in treating neuropathic pain. 


Marathon Oil (NYSE: MRO) will acquire PayRock Energy for approximately $888 million.

 

The Biomedical Advanced Research and Development Authority will provide up to $180 million to support Cerus' (Nasdaq: CERS) clinical development program for pathogen reduction of red blood cell components.


On the downside


Investors locked in profits on GlobeImmune (Nasdaq: GBIM).


Profit taking continued to weigh down shares of ChromaDex (Nasdaq: CDXC).


A proposed settlement of $140 million has been preliminarily approved for a class action lawsuit against Barrick Gold (NYSE: ABX).

 

In the broad market, advancing issues outpaced decliners by a margin of 6 to 1 on the NYSE and by more than 5 to 1 on Nasdaq. The broader S&P 500 surged 25 points to 2,096. Bitcoin tumbled $15 to $730.

Oil rebounds but markets drop

|

Crude oil prices rebounded but the markets closed lower with the Dow losing 57 points to 17,675 as British voters prepared for the Brexit referendum next week. Nasdaq tumbled 44 points to 4,800. 


On the upside


Speculation that GlobeImmune (Nasdaq: GBIM) may be an acquisition target sent shares of the biopharmaceutical soaring. 


Rising crude oil prices lifted shares of SM Energy (NYSE: SM).

 

Citizens Community Bancorp (Nasdaq: CZWI) retained the services of FIG Partners to explore strategic opportunities.


On the downside


Beijing ordered Apple (Nasdaq: AAPL) to halt sales of its iPhone 6 and iPhone 6 Plus.


Shares of Prothena (Nasdaq: PRTA) fell again.


Profit taking weighed down shares of Eleven Biotherapeutics (Nasdaq: EBIO).

 

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE while decliners edged out advancers by more than 9 to 7 on Nasdaq. The broader S&P 500 lost 6 points to 2,071. Bitcoin tumbled $17 to $736.

Markets lower at midday

|

The markets traded lower during the midday with the Dow losing 61 points to 17,671. Nasdaq tumbled 41 points to 4,803. 


On the upside


The U.S. Consumer Product Safety Commission ruled that a full recall of Lumber Liquidators' (NYSE: LL) laminate flooring that was made in China was not necessary. 


Teekay Offshore Partners (NYSE: TOO) announced a private placement of $200 million of equity securities.

 

Sky Solar Holdings (Nasdaq: SKYS) reported a smaller than expected loss for the first quarter.


On the downside


Innocoll Holdings (Nasdaq: INNL) priced its public offering of 5.725 million common shares at the discounted price of $7.00 per share.


Investors locked in profits on Violin Memory (NYSE: VMEM).


GlycoMimetics (Nasdaq: GLYC) priced its public offering of 3.3 million common shares at the discounted price of $6.10.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE while decliners edged out advancers by more than 9 to 7 on Nasdaq. The broader S&P 500 lost 6 points to 2,071. Bitcoin tumbled $17 to $736.

The markets opened lower with the Dow falling 70 points to 17,662 as the May unemployment rate rose in five states. Nasdaq tumbled 39 points to 4,805. 


On the upside


Revlon (NYSE: REV) will pay a premium of approximately $419 million in cash to acquire Elizabeth Arden (Nasdaq: RDEN). 


BioScrip (Nasdaq: BIOS) priced its public offering of 40 million common shares at $2.00 per share.

 

Jaguar Animal Health (Nasdaq: JAGX) reported positive results from a study conducted with Cornell University College of Veterinary Medicine evaluating the prophylactic use of a second-generation, powder formulation of Neonorm Calf.


On the downside


Comtech Telecommunications (Nasdaq: CMTL) priced its public offering of 7.145 million shares at the discounted price of $14.00 per share.


Synaptics (Nasdaq: SYNA) will cut 160 jobs and close some of its offices.


Investors locked in profits on Exact Sciences (Nasdaq: EXAS).

 

In the broad market, advancing issues outpaced decliners by a margin of 2 to 1 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 fell 9 points to 2,068. Bitcoin lost $20 to $733.

Upbeat homebuilder sentiment boosted the markets to a higher close with the Dow climbing 92 points to 17,733. Nasdaq gained 9 points to 4,844. 


On the upside


Vascular Biogenics (Nasdaq: VBLT) closed its $24 million registered direct offering. 


Shares of Biostar Pharmaceuticals (Nasdaq: BSPM) climbed for the third day in a row.

 

Bridgeline Digital (Nasdaq: PULM) entered a loan agreement with Heritage Bank of Commerce.


On the downside


Hynes Keller & Hernandez initiated an investigation into possible breaches of fiduciary duty by certain directors of Cobalt International Energy (NYSE: CIE).


Falling crude oil prices weighed down shares of SM Energy (NYSE: SM) and Whiting Petroleum (NYSE: WLL).


Investors locked in profits on Freeport-McMoRan (NYSE: FCX).

 

In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while delivers outpaced advancers by more than 10 to 9 on Nasdaq. The broader S&P 500 rose 6 points to 2,077. Bitcoin surged $66 to $747.

The markets recovered early morning losses to trade flat during the midday with the Dow adding a point to 17,641 as homebuilder sentiment rose. Nasdaq lost 14 points to 4,820. 


On the upside


Canaccord Genuity upgraded Advanced Micro Devices (Nasdaq: AMD) from a Hold rating to a Buy rating and lifted its price target from $3.25 to $6.00. 


Capricor Therapeutics (Nasdaq: CAPR) reported positive preliminary 12-month data from its DYNAMIC clinical trial of CAP-1002 in patients with advanced heart failure.

 

Shares of Pulmatrix (Nasdaq: PULM) surged again.


On the downside


Falling crude oil prices weighed down shares of California Resources (NYSE: CRC) and Vanguard Natural Resources (Nasdaq: VNR).


Analysts said that Valeant Pharmaceuticals (NYSE: VRX) must sell its underperforming assets.


Bank of America Merrill Lynch downgraded American Airlines (Nasdaq: AAL) from a Neutral rating to an Underperform rating.

 

In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 eased a fraction to 2,070. Bitcoin surged $46 to $727.

Crude oil prices fell below $47 per barrel to weigh the markets down to a sharply lower open with the Dow plummeting 136 points to 17,502. Nasdaq plunged 49 points to 4,785. 


On the upside


The U.S. Preventive Services Task Force included Exact Sciences' (Nasdaq: EXAS) Cologuard as one of several colorectal cancer screening tests. 


Cavium (Nasdaq: CAVM) will acquire QLogic (Nasdaq: QLGC) in a transaction valued at approximately $1.36 billion.

 

Nu Skin Enterprises (NYSE: NUS) received a $210 million strategic investment from Ping An ZQ China Growth Opportunity Limited.


On the downside


Tonix Pharmaceuticals (Nasdaq: TNXP) priced its public offering of 5 million common shares at the discounted price of $2.00 per share.


Korn/Ferry International (NYSE: KFY) reported sharply lower fourth quarter earnings and forecast current quarter results below expectations prompting a downgrade.


TETRA Technologies (NYSE: TTI) priced its public offering of 10 million common shares at the discounted price of $5.50 per share.

 

In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The broader S&P 500 tumbled 18 points to 2,052. Bitcoin leaped $38 to $719.

The Federal Reserve held interest rates steady but trimmed its economic growth forecast which sent the markets down to a lower close with the Dow falling 34 points to 17,640. Nasdaq lost 8 points to 4,834. 


On the upside


Shares of Helios and Matheson Analytics (Nasdaq: HMNY) surged on no news. 


TravelCenters of America (NYSE: TA) rejected an acquisition offer from Golden Gate Capital.

 

Ebix offered a premium of %9.50 per share to buy Patriot National (NYSE: PN).


On the downside


Investors locked in profits on Cray (Nasdaq: CRAY).


Rumors that Perrigo (NYSE: PRGO) may be acquired faded.


Shares of Global Blood Therapeutics (Nasdaq: GBT) fell for the fourth day.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 lost 3 points to 2,071. Bitcoin rose $2 to $682.

The markets traded higher during the midday with the Dow rising 36 points to 17,711 ahead of the Federal Reserve's interest rate decision today. Nasdaq gained 15 points to 4,859. 


On the upside


J.C. Penney (NYSE: JCP) chief executive Marvin Ellison said that Memorial Day weekend sales rebounded. 


Bargain hunters lifted shares of Infinity Pharmaceuticals (Nasdaq: INFI).

 

Bank of America/Merrill Lynch upgraded U. S. Steel (NYSE: X) from an Underperform rating to a Neutral rating.


On the downside


Profit taking weighed down shares of Five9 (Nasdaq: FIVN).


Bob Evans Farms (Nasdaq: BOBE) reported sharply lower fourth quarter earnings and forecast 2017 earnings below analyst estimates.


The Food and Drug Administration issued a warning letter to Whole Foods (Nasdaq: WFM) for serious violations at a food preparation facility in Massachusetts.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by 2 to 1 on Nasdaq. The broader S&P 500 gained 5 points to 2,081. Bitcoin edged up $1 to $681.

Produce prices rose 0.4% in May to lift the markets to a higher open with the Dow gaining 49 points to 17,724. Nasdaq rose 7 points to 4,851. 


On the upside


An upcoming article in the June 21 edition of the Journal of American Medical Association that appeared to put Exact Sciences' (Nasdaq: EXAS) Cologuard DNA colon cancer screening test on par with colonoscopy was leaked online. 


Aegerion Pharmaceuticals (Nasdaq: AEGR)  will merge with QLT (Nasdaq: QLTI).

 

Cellectar Biosciences (Nasdaq: CLRB) reported positive results from a preliminary tumor-targeting study of CLR 1602.


On the downside


Carbylan Therapeutics (Nasdaq: CBYL) entered a share purchase agreement with KalVista Pharmaceuticals in which KalVista shareholders would become the majority owners of Carbylan.


Scorpio Bulkers (NYSE: SALT) priced its public offering of 20 million common shares at the discounted price of $3.05 per share.


Investors locked in profits on Leading Brands (Nasdaq: LBIX).

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 gained 5 points to 2,081. Bitcoin slipped $1 to $679.

German bond yields fell into negative territory to weigh the markets down to a lower close with the Dow dropping 57 points to 17,674. Nasdaq slipped 4 points to 4,843. 


On the upside


Exact Sciences (Nasdaq: EXAS) will present at the William Blair 36th Annual Growth Stock Conference tomorrow in Chicago. 


First quarter earnings slipped for Motorcar Parts of America (Nasdaq: MPAA) but revenue climbed.

 

Shares of Perrigo (NYSE: PRGO) extended its gains.


On the downside


Stifel downgraded Navistar International (NYSE: NAV) from a Hold rating to a Sell rating.


Seven companies have expressed interest in buying Petrobras' (NYSE: PBR) Japanese unit on Okinawa.


The sale of Citigroup's (NYSE: C) Brazilian retail banking operations could take up to three months.

 

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 lost 3 points to 2,075. Bitcoin tumbled $15 to $674.

Markets lower as prices rise

|

The markets traded lower during the midday with the Dow tumbling 80 points to 17,652 as import and export prices rose. Nasdaq dropped 20 points to 4,828. 


On the upside


Yingli Green Energy (NYSE: YGE) reversed year ago losses to post a profit for the first quarter and modified its loan agreement. 


Biostar Pharmaceuticals (Nasdaq: BSPM) shareholders elected five directors and appointed Mazars CPA as the company's independent registered public accounting firm.

 

Alibaba (NYSE: BABA) expects transaction volumes to top $912 billion by 2020.


On the downside


Dataram (Nasdaq: DRAM) will acquire US Gold.


Synchrony Financial (NYSE: SYF) warned of higher charge-off rates.


ArcelorMittal (NYSE: MT) will purchase up to $600 million principal amount of its outstanding notes.

 

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 dropped 8 points to 2,070. Bitcoin plunged $25 to $665.

Retail sales rose 0.5% in May but the markets opened lower with the Dow tumbling 76 points to 17,655 as crude oil prices continued to slip. Nasdaq fell 15 points to 4,833. 


On the upside


Leading Brands (Nasdaq: LBIX) swung to a profit for the first quarter. 


Wedbush upgraded Achaogen (Nasdaq: AKAO) from a Neutral rating to an Outperform rating.

 

Insider Monkey noted that more hedge funds took positions in Vonage (Nasdaq: VG) in the first quarter.


On the downside


Infinity Pharmaceuticals (Nasdaq: INFI) halted a Phase 1b/2 study of duvelisib after disappointing results and will eliminate 46 research jobs.


Revance Therapeutics (Nasdaq: RVNC) reported disappointing results from a Phase 3 trial of RT001 to treat crow's feet.


ImmunoGen (Nasdaq: IMGN) will offer $100 million in convertible senior notes through a private placement.

 

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 fell 6 points to 2,072. Bitcoin dropped $10 to $680.

A drop in global markets sent domestic markets tumbling to a sharply lower close with the Dow plummeting 132 points to 17,732. Nasdaq plunged 46 points to 4,848. 


On the upside


Shares of Smith & Wesson (Nasdaq: SWHC) and Sturm, Ruger & Co. (NYSE: RGR) climbed in the wake of the deadly Orlando mass shooting. 


Rising gold prices lifted shares of Barrick Gold (NYSE: ABX).

 

Jefferies lifted its price target on Advanced Micro Devices (Nasdaq: AMD) from $4.50 to $5.50.


On the downside


BioScrip (Nasdaq: BIOS) will acquire HS Infusion Holdings in a cash and stock deal valued at approximately $85 million.


Zynga (Nasdaq: ZNGA) named Bernard Kim to the position of President of Publishing.


Capital Cube wrote that Intelsat (NYSE: I) was undervalued but the stock price fell.

 

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 1 on the NYSE and by 3 to 1 on Nasdaq. The broader S&P 500 tumbled 17 points to 2,079. Bitcoin surged $26 to $679.

Losses extended at midday

|

The markets extended its losses during the midday with the Dow falling 69 points to 17,796 as crude oil prices slipped. Nasdaq dropped 34 points to 4,860. 


On the upside


The Sunday Times reported that Rio Tinto (NYSE: RIO) was exploring the option of taking Turquoise Hill (NYSE: TRQ) private. 


Microsoft's (Nasdaq: MSFT) 426.2 billion acquisition of LinkedIn (NYSE: LNKD) sparked speculation that Twitter (NYSE: TWTR) may be acquired.

 

Symantec (Nasdaq: SYMC) will pay approximately $4.6 billion in cash to acquire Blue Coat Systems.


On the downside


Shares of Petrobras (NYSE: PBR) fell after rival Ultrapar Participacoes (NYSE: UGP) announced plans to acquire Alesat Combustveis.


Raymond James downgraded OraSure Technologies (Nasdaq: OSUR) from an Outperform rating to a Market Perform rating.


An independent data monitoring committee recommended that Argos Therapeutics (Nasdaq: ARGS) continue its Phase 3 ADAPT clinical trial of AGS-003 to treat metastatic renal cell carcinoma but the stock price dropped.

 

In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 fell 10 points to 2,085. Bitcoin leaped $30 to $683.

The markets opened lower with the Dow slipping 10 points to 17,855 ahead of the Federal Reserve's policy meeting beginning tomorrow. Nasdaq lost 7 points to 4,886. 


On the upside


LinkedIn (NYSE: LNKD) will be acquired by Microsoft (Nasdaq: MSFT) in an all-cash deal valued at approximately $26.2 billion. 


Eleven Biotherapeutics (Nasdaq: EBIO) entered an exclusive license agreement for Roche to develop and commercialize EBI-031.

 

Shares of COPsync (Nasdaq: COYN) surged in the aftermath of Orlando's deadly mass shooting early Sunday morning.


On the downside


Marinus Pharmaceuticals (Nasdaq: MRNS) reported disappointing results from a Phase 3 study of ganaxolone to treat adults with drug-resistant focal onset seizures.


DA Davidson downgraded Emerge Energy Services (NYSE: EMES) from a Buy rating to an Underperform rating.


Insider Monkey noted that hedge funds increased their holdings in ArcelorMittal (NYSE: MT) in the first quarter but the stock price fell.

 

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 slipped a point to 2,094. Bitcoin leaped $41 to $694.

The markets closed sharply lower with the Dow plummeting 119 points to 17,865 as crude oil prices fell below $49 per barrel. Nasdaq plunged 64 points to 4,894. 


On the upside


Harte-Hanks (NYSE: HHS) stock rose for the fourth day in a row. 


Global Blood Therapeutics (Nasdaq: GBT) reported new results from an ongoing Phase 1/2 GBT 440-001 study in sickle cell disease.

 

The New York Post reported that the proposed merger between Rite Aid (NYSE: RAD) and Walgreens (NYSE: WBA) would likely be approved by regulators.


On the downside


Citigroup downgraded Dynegy (NYSE: DYN) from a Buy rating to a Neutral rating.


Southwestern Energy (NYSE: SWN) entered an agreement to sell 55,000 net acres in West Virginia to Antero Resources.


Falling crude oil prices weighed down shares of SM Energy (NYSE: SM).

 

In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by 7 to 2 on Nasdaq. The broader S&P 500 tumbled 19 points to 2,096. Bitcoin rose $4 to $572.

Crude oil prices retreated again to send the markets lower during the midday with the Dow tumbling 94 points to 17,891. Nasdaq plummeted 50 points to 4,907. 


On the upside


Bargain hunters lifted shares of Eagle Pharmaceuticals (Nasdaq: EGRX). 


H&R Block (NYSE: HRB) reported higher fourth quarter earnings and increased its quarterly dividend.

 

Shares of Emerge Energy Services (NYSE: EMES) surged again.


On the downside


Retreating crude oil prices weighed down shares of California Resources (NYSE: CRC) and Whiting Petroleum (NYSE: WLL).


Investors locked in profits on Second Sight Medical Products (Nasdaq: EYES).


The Shuman Law Firm initiated an investigation into possible breach of fiduciary duties by certain executives of Cobalt International Energy (NYSE: CIE).

 

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 2 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 tumbled 16 points to 2,098. Bitcoin added $1 to $569.

The markets tumbled at the open with the Dow plummeting 128 points to 17,856 as the German 10-year bund yield fell to a record low. Nasdaq plunged 52 points to 4,905. 


On the upside


Sophiris Bio (Nasdaq: SPHS) reported positive results from a Phase 2a study of topsalysin to treat prostate cancer. 


Westlake Chemical will pay a premium of approximately $2.33 billion in cash to acquire Axiall (NYSE: AXLL).

 

Connecture (Nasdaq: CNXR) amended its credit agreement.


On the downside


Approximately 33 million Twitter (NYSE: TWTR) account usernames and passwords have been leaked.


Mattress Firm Holding (Nasdaq: MFRM) fell to a greater than expected loss for the first quarter, forecast current quarter earnings below estimates and cut its full year outlook.


Urban Outfitters (Nasdaq: URBN) warned that second quarter same store sales were falling.

 

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 1 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 plunged 18 points to 2,096. Bitcoin added $2 to $570.

A drop in crude oil prices weighed the markets down to a modestly lower close with the Dow slipping 19 points to 17,985. Nasdaq lost 16 points to 4,958. 


On the upside


Shares of Bellerophon Therapeutics (Nasdaq: BLPH) surged on no news. 


Emerge Energy Services (NYSE: EMES) climbed for the sixth day in a row.

 

Bargain hunters lifted shares of Second Sight Medical Products (Nasdaq: EYES).


On the downside


Profit taking continued to weigh down shares of Bridgeline Digital (Nasdaq: BLIN).


FuelCell Energy (Nasdaq: FCEL) widened second quarter losses more than expected.


Raymond James downgraded Health Insurance Innovations (Nasdaq: HIIQ) from a Strong Buy rating to a Market Perform rating.

 

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 slipped 3 points to 2,115. Bitcoin fell $6 to $567.

First time applications for unemployment benefits fell more than expected last week but the markets traded lower during the midday with the Dow tumbling 80 points to 17,925 as crude oil prices retreated. Nasdaq dropped 25 points to 4,949. 


On the upside


Rumors circulated AmSurg engaged in conversations with Envision Healthcare (NYSE: EVHC) for a potential merger. 


J.M. Smucker (NYSE: SJM) reversed year ago losses to post a stronger than expected profit for the fourth quarter.

 

Sarepta Therapeutics (Nasdaq: SRPT) will raise approximately $37.5 million through the sale of its common stock.


On the downside


Investors continued to lock in profits on Immunomedics (Nasdaq: IMMU).


Profit taking weighed down shares of Vale (NYSE: VALE).


Agios Pharmaceuticals (Nasdaq: AGIO) reported initial data from a Phase 1 clinical trial of AG-519.

 

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 fell 9 points to 2,109. Bitcoin fell $5 to $569.

The markets opened lower with the Dow dropping 79 points to 17,925 as crude oil prices retreated. Nasdaq fell 21 points to 4,953. 


On the upside


Jaguar Animal Health (Nasdaq: JAGX) entered a $15 million common stock purchase agreement and a registration rights agreement with Aspire Capital Fund. 


Staffing 360 Solutions (Nasdaq: STAF) reported higher preliminary full year and fourth quarter revenue.

 

Great Basin Scientific (Nasdaq: GBSN) will exhibit its diagnostic platform at the ASM Microbe 2016.


On the downside


Restoration Hardware (NYSE: RH) fell to a greater than expected loss of the first quarter, forecast current quarter earnings below estimates and cut its full year guidance.


Tailored Brands (NYSE: TLRD) disappointed with sharply lower first quarter results that missed estimates.


Profit taking sank shares of Biostar Pharmaceuticals (Nasdaq: BSPM).

 

In the broad market, declining issues outpaced advancers by a margin of 3 to 1 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 fell 9 points to 2,110. Bitcoin fell $5 to $569.

Crude oil prices rose above $51 per barrel to lift the markets to a higher close with the Dow climbing 66 points to 18,005. Nasdaq gained 12 points to 4,974. 


On the upside


Shares of Biostar Pharmaceuticals (Nasdaq: BSPM) tripled on no news. 


Companhia Siderurgica Nacional (NYSE: SID) stock climbed on AK Steel's upgrade (NYSE: AKS).

 

Skullcandy (Nasdaq: SKUL) founder Richard Alden was exploring a potential deal to take the company private.


On the downside


Investors continued to lock in profits on Minerva Neurosciences (Nasdaq: NERV).


MTS Systems (Nasdaq: MTSC) announced a public offering of 1.5 million shares of common stock.


Shares of Southwestern Energy (NYSE: SWN) extended its losses.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by a margin of more than 5 to 3 on Nasdaq. The broader S&P 500 gained 6 points to 2,119. Bitcoin added $2 to $577.

The markets continued to rise during the midday with the Dow gaining 55 points to 17,993 as the number of job openings hit a record high. Nasdaq rose 13 points to 4,975. 


On the upside


The Weisman Group made an unsolicited offer to acquire Ashford Hospitality Prime (NYSE: AHP). 


Motley Fool wrote that Calumet Specialty Products Partners (Nasdaq: CLMT) was undervalued.

 

The Oklahoma City Police Department determined that the car accident that killed former Chesapeake Energy (NYSE: CHK) chief executive Aubrey McClendon was not a suicide.


On the downside


Fibrocell Science (Nasdaq: FCSC) reported disappointing results from a Phase II clinical trial of azficel-T to treat vocal cord scarring from chronic or severe dysphonia.


Shares of Vascular Biogenics (Nasdaq: VBLT) extended its losses.


Jefferies downgraded Sunoco (NYSE: SUN) from a Hold rating to an Underperform rating.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by a margin of more than 3 to 2 on Nasdaq. The broader S&P 500 gained 5 points to 2,117. Bitcoin added $1 to $571.

The markets opened higher with the Dow gaining 34 points to 17,972 as crude oil prices continued to rise. Nasdaq slipped a point to 4,960. 


On the upside


Bridgeline Digital (Nasdaq: BLIN) launched their new iAPPS Pro product line that offers fully integrated marketing automation, web content management and eCommerce capabilities. 


Credit Suisse upgraded AK Steel (NYSE: AKS) from an Underperform rating to an Outperform rating.

 

Shares of Helios and Matheson Analytics (Nasdaq: HMNY) surged for the third straight day.


On the downside


VeriFone Systems (NYSE: PAY) disappointed with lower second quarter earnings that fell short of expectations, forecast current quarter as well as full year results below estimates and announced plans to cut jobs.


Ardmore Shipping (NYSE: ASC) priced its public offering of common stock at the discounted price of $8.90 per share.


Flexion Therapeutics (Nasdaq: FLXN) priced its public offering of common stock at the discounted price of $15 per share.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by a margin of nearly 5 to 4 on Nasdaq. The broader S&P 500 gained 6 points to 2,118. Bitcoin added $2 to $572.

The markets closed mixed with the Dow rising 17 points to 17,938 after the World Bank trimmed its global economic expansion forecast from 2.9% to 2.4%. Nasdaq lost 6 points to 4,961. 


On the upside


Rising crude oil prices lifted shares of California Resources (NYSE: CRC). 


Navistar International (NYSE: NAV) swung to a greater than expected profit for the second quarter.

 

Consolidate Communications (Nasdaq: CNSL) selected Synacor's (Nasdaq: SYNC) End-to-End Video Solutions to provide enhanced TV Everywhere apps.


On the downside


Catalent (NYSE: CTLT) announced a secondary offering of its common shares.


The Department of Education asked ITT Educational Services (NYSE: ESI) to provide evidence that it had sufficient funds to refund students if the for-profit educator shuts down.


A federal judge overturned a jury's ruling that Gilead (Nasdaq: GILD) infringed on two patents owned by Merck (NYSE: MRK) and Ionis Pharmaceuticals (Nasdaq: IONS).

 

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The broader S&P 500 added 2 points to 2,112. Bitcoin lost $7 to $570.

Markets advance at midday

|

The markets advanced during the midday with the Dow climbing 74 points to 17,994 as crude oil prices edged up. Nasdaq rose 9 points to 4,978. 


On the upside


Shares of Helios and Matheson Analytics (Nasdaq: HMNY) continued soaring. 


Aehr Test Systems (Nasdaq: AEHR) received the first order for its new FOX-XP production test cells.

 

Pacific Drilling (NYSE: PACD) resumes trading after being halted.


On the downside


Biogen (Nasdaq: BIIB) reported disappointing results from a Phase 2 study of its multiple sclerosis treatment opicinumab.


Alexion Pharmaceuticals' (Nasdaq: ALXN) myasthenia gravis treatment Soliris failed a Phase 3 clinical study.


The Michaels Companies (Nasdaq: MIK) reported higher first quarter earnings and revenue but the company forecast current quarter earnings below estimates.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 gained 9 points to 2,118. Bitcoin dropped $11 to $566.

Crude oil prices rose above $50 per barrel to lift the markets to a higher open with the Dow gaining 60 points to 17,981. Nasdaq added 2 points to 4,970. 


On the upside


Zimmer Biomet (NYSE: ZBH) will acquire LDR (Nasdaq: LDRH) in an all cash deal valued at approximately $1 billion. 


Sarepta Therapeutics (Nasdaq: SRPT) will submit dystrophin data to the Food and Drug Administration ahead of clinical reviews for accelerated approval of eteplirsen to treat Duchenne muscular dystrophy.

 

China Auto Logistics (Nasdaq: CALI) sold its Zhonghe subsidiary to Wuxi Huitong Automobile Sales and Services for approximately $62.3 million.


On the downside


Valeant Pharmaceuticals (NYSE: VRX) fell to a greater than expected loss for the first quarter prompting the company to cut its full year forecast.


DryShips (Nasdaq: DRYS) defaulted on three loans totaling $213.7 million.


Vascular Biogenics (Nasdaq: VBLT) announced a registered direct offering.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE while decliners edged out advancers by more than 10 to 9 on Nasdaq. The broader S&P 500 rose 4 points to 2,114. Bitcoin added $3 to $581.

Federal Reserve chair Janet Yellen indicated that the timeline for interest rate increases was uncertain which investors interpreted to mean no rate hikes in June. The markets closed sharply higher with the Dow soaring 113 points to 17,920. Nasdaq gained 26 points to 4,968. 


On the upside


ManpowerGroup (NYSE: MAN) will acquire the Dutch business of Ciber (NYSE: CBR). 


Rising crude oil prices lifted shares of Chesapeake Energy (NYSE: CHK).

 

Tribune Publishing (NYSE: TPUB) shareholders support selling the company to Gannett (NYSE: GCI).


On the downside


Investors locked in profits on Corbus Pharmaceuticals (Nasdaq: CRBP).


JMP Securities downgraded Barracuda Networks (NYSE: CUDA) from a Market Perform rating to a Market Underperform rating.


Sasol (NYSE: SSL) warned of lower full year earnings.

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 gained 10 points to 2,109. Bitcoin climbed $12 to $578.

The markets traded higher during the midday with the Dow gaining 62 points to 17,869 as Federal Reserve chair Janet Yellen speaks at the World Affairs Council of Philadelphia. Nasdaq rose 11 points to 4,954. 


On the upside


Helios and Matheson Analytics (Nasdaq: HMNY) will merge with Zone Technologies. 


Cyclacel Pharmaceuticals (Nasdaq: CYCC) reported updated Phase 1 data from its DNA damage response program evaluating a combination of seliciclib and sapacitabine.

 

Rising crude oil prices lifted shares of Bonanza Creek Energy (NYSE: BCEI).


On the downside


Immunomedics (Nasdaq: IMMU) reported disappointing results for its lung cancer treatment IMMU-132.


Jefferies downgraded Mirati Therapeutics (Nasdaq: MRTX) from a Buy rating to a Hold rating while Leerink Partners downgraded the company from an Outperform rating to Market Perform.


Profit taking weighed down shares of Eleven Biotherapeutics (Nasdaq: EBIO).

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 added 3 points to 2,102. Bitcoin climbed $14 to $580.

Crude oil prices rose again to lift the markets to a higher open with the Dow climbing 93 points to 17,900. Nasdaq gained 16 points to 4,958. 


On the upside


Vascular Biogenics (Nasdaq: VBLT) presented upbeat Phase 1/2 results for VB-111 to treat recurrent platinum resistant ovarian cancer patients. 


Oncothyreon (Nasdaq: ONTY) presented promising results from a Phase 1b study of ONT-380 to treat HER2+ advanced or metatstatic breast cancer.

 

Shares of Cemtrex (NYSE: CETX) rose ahead of its presentation at the 6th Annual LD Micro Invitational tomorrow.


On the downside


ProNAi Therapeutics (Nasdaq: DNAI) suspended development of PNT2258 after disappointing results from a Phase 2 trial.


The Food and Drug Administration issued a Complete Response Letter to Adamis Pharmaceuticals (Nasdaq: ADMP) for its pre-filled single dose epinephrine syringe product.


Ocular Therapeutix (Nasdaq: OCUL) reported disappointing results from a second Phase 3 clinical trial of DEXTENZA to treat allergic conjunctivitis.

 

In the broad market, advancing issues outpaced decliners by a margin of 5 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 gained 9 points to 2,108. Bitcoin climbed $12 to $578.

Rising crude oil prices and a higher trade deficit weighed the markets down to a lower close with the Dow losing 31 points to 17,807. Nasdaq dropped  28 points to 4,942. 


On the upside


Bargain hunters lifted shares of Carbylan Therapeutics (Nasdaq: CBYL). 


Delta Air Lines (NYSE: DAL) and United Continental Holdings (NYSE: UAL) may invest in struggling Colombian airline Avianca Holdings (NYSE: AVH).

 

Piper Jaffray upgraded Weatherford International (NYSE: WFT) from a Neutral rating to an Overweight rating.


On the downside


Profit taking weighed down shares of Celldex Therapeutics (Nasdaq: CLDX).


Retreating crude oil prices weighed down shares of Chesapeake Energy (NYSE: CHK).


Shares of LendingClub (NYSE: LC) fell after the New York Department of Financial Services initiated an inquiry into online lenders.

 

In the broad market, advancing issues outpaced decliners by a margin of more than 10 to 9 on the NYSE while decliners edged out advancers by more than 5 to 3 on Nasdaq. The broader S&P 500 lost 6 points to 2,099. Bitcoin surged $34 to $565.

The markets traded lower during the midday with the Dow falling 51 points to 17,787 as the nation added a lower than expected 38,000 jobs last month. Nasdaq tumbled 35 points to 4,935. 


On the upside


Lion Biotechnologies (Nasdaq: LBIO) raised approximately $100 million through a private placement and named Maria Fardis, Ph.D. to the position of president and chief executive officer. 


Rising gold prices lifted shares of Alamos Gold (NYSE: AGI) and Kinross Gold (NYSE: KGC).

 

Ambarella (Nasdaq: AMBA) reported better than expected first quarter earnings and revenue.


On the downside


Investors locked in profits on Keryx Biopharmaceuticals (Nasdaq: KERX).


Profit taking weighed down share of SouFun Holdings (NYSE: SFUN).


Investors locked in profits on Minerva Neurosciences (Nasdaq: NERV).

 

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 dropped 10 points to 2,095. Bitcoin soared $25 to $556.

The nation's trade deficit rose 5.3% to $37.4 billion sending the markets tumbling to a sharply lower open with the Dow plummeting 130 points to 17,708. Nasdaq plunged 54 points to 4,916. 


On the upside


Coffee Holding Company (Nasdaq: JVA) swung to a profit for the second quarter. 


Talen Energy (NYSE: TLN) will be acquired by Riverstone for a premium of approximately $1.2 billion.

 

Shares of Eleven Biotherapeutics (Nasdaq: EBIO) continued rising.


On the downside


The American Society of Clinical Oncology removed Immunomedics' (Nasdaq: IMMU) presentation from its conference for presenting old clinical data.


American Airlines (Nasdaq: AAL) selected ViaSat instead of Gogo (Nasdaq: GOGO) to provide in-flight wi-fi service to a fleet of 100 Boeing 737 Max jets.


Rumors circulated that The Chemours Company (NYSE: CC) may file for bankruptcy.

 

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 tumbled 17 points to 2,087. Bitcoin soared $21 to $552.

The markets markets recovered to close higher with the Dow gaining 48 points to 17,838 despite a disappointing jobs report. Nasdaq rose 19 points to 4,971. 


On the upside


Eleven Biotherapeutics (Nasdaq: EBIO) regained compliance with the Nasdaq Listing Rule. 


Cellectar Biosciences (Nasdaq: CLRB) will present at the LD Micro Invitational on Thursday, June 9, 2016.

 

Joy Global (NYSE: JOY) reported a smaller than expected loss for the second quarter.


On the downside


Ocean Power Technologies (Nasdaq: OPTT) priced its registered direct offering of 417,000 common shares at the discounted price of $4.60 per share.


Mitek (Nasdaq: MITK) will present at several upcoming investor conferences.


Fourth quarter earnings for American Woodmark (Nasdaq: AMWD) fell short of expectations.

 

In the broad market, advancing issues outpaced decliners by a margin of 5 to 4 on the NYSE and by more than 4 to 3 on Nasdaq. The broader S&P 500 rose 5 points to 2,105. Bitcoin edged up to $530.

The markets opened lower with the Dow falling 68 points to 17,720 as fewer than expected jobs were created in May. Nasdaq lost 16 points to 4,936.

On the upside

Broadwind Energy (Nasdaq: BWEN) will supply wind turbine towers to a wind turbine manufacturer for approximately $137 million.

Ciena (NYSE: CIEN) reported better than expected earnings and revenue for the second quarter.
 
Achaogen (Nasdaq: AKAO) received a $20 million contract to support the development of plazomicin to treat bacterial infections.

On the downside

Conns (Nasdaq: CONN) fell to a greater than expected loss for the first quarter.

Investors locked in profits on Sarepta Therapeutics (Nasdaq: SRPT).

Box (NYSE: BOX) reported a smaller than expected loss for the first quarter but billings fell short of estimates.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 lost 6 points to 2,092. Bitcoin slipped $1 to $528.

Flat close over rate concerns

|
The markets closed flat with the Dow adding 2 points to 17,789 despite upbeat manufacturing activity as investors worried about an interest rate increase. Nasdaq rose 4 points to 4,952.

On the upside

Minerva Neurosciences (Nasdaq: NERV) will present at the Jefferies 2016 Healthcare Conference on June 8, 2016.

Shares of Herculers Offshore (Nasdaq: HERO) continued rising.
 
Cracker Barrel Old Country Store (Nasdaq: CBRL) reported higher third quarter earnings and revenue, increased its quarterly dividend, raised its full year earnings outlook and declared a special dividend.

On the downside

H.C. Wainwright downgraded Cymabay Therapeutics (Nasdaq: CBAY) from a Buy rating to a Neutral rating.

Raymond James downgraded Briggs & Stratton (NYSE: BGG) from a Strong Buy rating to a Market Perform rating.

Profit taking continued to weigh down shares of Vivint Solar (NYSE: VSLR).
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 added 2 points to 2,099. Bitcoin gained $7 to $529.
Falling crude oil prices tempered enthusiasm for a greater than expected gain in May manufacturing activity. The markets traded mixed during the midday with the Dow slipping 15 points to 17,771 while Nasdaq rose 6 points to 4,954.

On the upside

Valeant Pharmaceuticals (NYSE: VRX) will report first quarter results on June 7, 2016.

Viking Therapeutics (NYSE: VKTX) chief executive Brian Lian, Ph.D. will present at the 2016 Marcum Microcap Conference this afternoon.
 
CombiMatrix (Nasdaq: CBMX) will begin accepting samples for pre-implantation genetic screening by next generation sequencing in mid-June.

On the downside

Daktronics (Nasdaq: DAKT) fell to a greater than expected loss for the fourth quarter as revenue dropped.

Adeptus Health (NYSE: ADPT) forecast second quarter results below analyst estimates and announced that it will offer 2.75 million shares of common stock.

ChemoCentryx (Nasdaq: CCXI) received Priority Medicines (PRIME) designation from the European Medicines Agency for CCX168 to treat ANCA-Associated Vasculitis but the stock price fell.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 held steady at 2,096. Bitcoin gained $7 to $529.
Retreating crude oil prices weighed the markets down to a lower open with the Dow falling 75 points to 17,711. Nasdaq lost 13 points to 4,934.

On the upside

The Food and Drug Administration granted Fast Track designation to Galena Biopharma's (Nasdaq: GALE) NeuVax.

Salesforece.com (NYSE: CRM) will pay a premium of approximately $2.8 billion in cash to acquire Demandware (NYSE: DWRE).
 
Ocean Power Technologies (Nasdaq: OPTT) entered into a PB3 PowerBuoy lease agreement with Mitsui Engineering and Shipbuilding.

On the downside

Profit taking weighed down shares of B.O.S. Better Online Solutions (Nasdaq: BOSC).

Ascena Retail Group (Nasdaq: ASNA) reported lower third quarter earnings as revenue fell short of expectations prompting the retailer to lower its full year forecast.

Freeport-McMoRan (NYSE: FCX) completed the sale of a 13% stake in Morenci Mine.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 3 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 lost 5 points to 2,091. Bitcoin climbed $11 to $533.

About this Archive

This page is an archive of entries from June 2016 listed from newest to oldest.

May 2016 is the previous archive.

July 2016 is the next archive.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12